• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

作者信息

Hussain Abdulzahra, Vasas Peter, El-Hasani Shamsi

机构信息

Doncaster and Bassetlaw Teaching Hospital, Doncaster, UK..

Doncaster and Bassetlaw Teaching Hospital, Doncaster, UK.

出版信息

Metabolism. 2020 Jul;108:154256. doi: 10.1016/j.metabol.2020.154256. Epub 2020 Apr 29.

DOI:10.1016/j.metabol.2020.154256
PMID:32360211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7189834/
Abstract
摘要

相似文献

1
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.致编辑的信：肥胖作为代谢相关脂肪性肝病患者中COVID-19病情更严重的危险因素
Metabolism. 2020 Jul;108:154256. doi: 10.1016/j.metabol.2020.154256. Epub 2020 Apr 29.
2
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.致编辑的信：肥胖作为代谢相关脂肪性肝病患者感染 COVID-19 时病情更严重的风险因素。
Metabolism. 2020 Jul;108:154244. doi: 10.1016/j.metabol.2020.154244. Epub 2020 Apr 19.
3
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease.在代谢相关脂肪性肝病中，没有证据表明严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的肝脏摄取增加。
J Hepatol. 2020 Sep;73(3):717-718. doi: 10.1016/j.jhep.2020.04.035. Epub 2020 Apr 30.
4
Commentary: Obesity: The "Achilles heel" for COVID-19?评论：肥胖：新冠病毒的“阿喀琉斯之踵”？
Metabolism. 2020 Jul;108:154251. doi: 10.1016/j.metabol.2020.154251. Epub 2020 Apr 27.
5
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.代谢功能障碍相关脂肪性肝病且纤维化评分升高的患者感染新型冠状病毒肺炎后出现重症的风险。
Gut. 2020 Aug;69(8):1545-1547. doi: 10.1136/gutjnl-2020-321611. Epub 2020 May 15.
6
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.致编辑的信：糖尿病患者中的 COVID-19：增加发病率的风险因素。
Metabolism. 2020 Jul;108:154224. doi: 10.1016/j.metabol.2020.154224. Epub 2020 Apr 7.
7
Letter to the Editor: Importance of metabolic health in the era of COVID-19.致编辑的信：新冠疫情时代代谢健康的重要性。
Metabolism. 2020 Jul;108:154247. doi: 10.1016/j.metabol.2020.154247. Epub 2020 Apr 22.
8
In Reply to the Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community".致编辑的信的回复，主题为“冠状病毒病（COVID-19）的神经学影响：神经科学界的实际考量” 。
World Neurosurg. 2020 Oct;142:535-536. doi: 10.1016/j.wneu.2020.06.115. Epub 2020 Jun 23.
9
Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community".致编辑的信：关于“冠状病毒病（COVID-19）对神经系统的影响：神经科学界的实际考量”
World Neurosurg. 2020 Oct;142:533-534. doi: 10.1016/j.wneu.2020.05.089. Epub 2020 May 17.
10
Letter to the Editor: "Role of the Neurosurgeon in Times of Coronavirus Disease 2019 (COVID-19): The Importance of Focus in Critical Care".致编辑的信：“神经外科医生在2019年冠状病毒病（COVID-19）时期的角色：重症监护中专注的重要性”
World Neurosurg. 2020 Nov;143:624. doi: 10.1016/j.wneu.2020.08.059.

引用本文的文献

1
An overview of SARS-COV-2-related hepatic injury.新型冠状病毒肺炎相关肝损伤概述
Hepatol Forum. 2021 Sep 15;2(3):122-127. doi: 10.14744/hf.2021.2021.0020. eCollection 2021 Sep.
2
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.COVID-19 与合并症：风险、协同作用和临床结局。
Front Immunol. 2022 May 27;13:890517. doi: 10.3389/fimmu.2022.890517. eCollection 2022.
3
Viral Clearance Course of COVID-19 Outbreaks.新冠疫情的病毒清除过程
J Multidiscip Healthc. 2021 Mar 4;14:555-565. doi: 10.2147/JMDH.S302891. eCollection 2021.
4
Liver injury in the era of COVID-19.COVID-19 时代的肝损伤。
World J Gastroenterol. 2021 Feb 7;27(5):377-390. doi: 10.3748/wjg.v27.i5.377.
5
Obesity in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者中的肥胖症：系统评价和荟萃分析。
Metabolism. 2020 Dec;113:154378. doi: 10.1016/j.metabol.2020.154378. Epub 2020 Sep 28.
6
Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis.体重指数（BMI）与重症 COVID-19 和住院死亡率的关系：剂量反应荟萃分析。
Metabolism. 2021 Apr;117:154373. doi: 10.1016/j.metabol.2020.154373. Epub 2020 Sep 16.
7
Body Mass Index and Prognosis of COVID-19 Infection. A Systematic Review.体重指数与新型冠状病毒肺炎感染的预后：一项系统评价
Front Endocrinol (Lausanne). 2020 Aug 14;11:562. doi: 10.3389/fendo.2020.00562. eCollection 2020.
8
Obesity is a potential risk factor contributing to clinical manifestations of COVID-19.肥胖是导致 COVID-19 临床症状的一个潜在危险因素。
Int J Obes (Lond). 2020 Dec;44(12):2479-2485. doi: 10.1038/s41366-020-00677-2. Epub 2020 Sep 13.
9
Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD).随着我们从单纯性非酒精性脂肪性肝病（NAFLD）时代过渡到代谢相关脂肪性肝病（DAFLD）时代，NAFLD 取得了进展。
Metabolism. 2020 Oct;111S:154318. doi: 10.1016/j.metabol.2020.154318. Epub 2020 Jul 21.
10
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study.低血浆 25(OH) 维生素 D 水平与 COVID-19 感染风险增加相关：一项以色列基于人群的研究。
FEBS J. 2020 Sep;287(17):3693-3702. doi: 10.1111/febs.15495. Epub 2020 Aug 28.

本文引用的文献

1
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.致编辑的信：肥胖作为代谢相关脂肪性肝病患者感染 COVID-19 时病情更严重的风险因素。
Metabolism. 2020 Jul;108:154244. doi: 10.1016/j.metabol.2020.154244. Epub 2020 Apr 19.
2
Obesity is Associated with Severe Forms of COVID-19.肥胖与重症新型冠状病毒肺炎相关。
Obesity (Silver Spring). 2020 Jul;28(7):1175. doi: 10.1002/oby.22842. Epub 2020 May 21.
3
Risk of COVID-19 for patients with obesity.肥胖患者感染新冠病毒的风险。
Obes Rev. 2020 Jun;21(6):e13034. doi: 10.1111/obr.13034. Epub 2020 Apr 13.
4
Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations.非酒精性脂肪性肝病：日益加重的负担、不良后果及关联
J Clin Transl Hepatol. 2020 Mar 28;8(1):76-86. doi: 10.14218/JCTH.2019.00051. Epub 2019 Dec 28.
5
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）需要有创机械通气患者中肥胖的高患病率。
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199. doi: 10.1002/oby.22831. Epub 2020 Jun 10.
6
Nonalcoholic Steatohepatitis: A Review.非酒精性脂肪性肝炎：综述。
JAMA. 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298.
7
Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity.腹腔镜袖状胃切除术对日本重度肥胖非酒精性脂肪性肝炎和肝纤维化的影响。
Obes Surg. 2020 Jul;30(7):2579-2587. doi: 10.1007/s11695-020-04515-2.
8
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.非侵入性纤维化测量在非酒精性脂肪性肝病/非酒精性脂肪性肝炎中的应用：迄今进展
Pharmaceut Med. 2019 Dec;33(6):451-463. doi: 10.1007/s40290-019-00305-z.
9
Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.肥胖指数、代谢健康和脂肪组织炎症对减重手术患者非酒精性脂肪性肝病严重程度的影响：一项前瞻性研究。
Obes Surg. 2019 Jan;29(1):99-108. doi: 10.1007/s11695-018-3479-2.
10
Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery.非酒精性脂肪性肝炎与接受减肥手术的肥胖患者死亡率增加有关。
Clin Gastroenterol Hepatol. 2016 Nov;14(11):1619-1628. doi: 10.1016/j.cgh.2015.10.010. Epub 2015 Oct 20.